SRPT Form 3: CFO Ryan Wong holds 17,655 shares & 31k options
Sarepta Therapeutics (SRPT) Form 3 records newly appointed CFO Ryan Ho-Yan Wong’s initial beneficial ownership as of 16 Jul 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sarepta Therapeutics (SRPT) Form 3 records newly appointed CFO Ryan Ho-Yan Wong’s initial beneficial ownership as of 16 Jul 2025. He directly holds 17,655 common shares. The filing also lists 11 stock-option grants covering 31,031 shares with exercise prices between $67.78 and $155.99 and expirations from 2031-2035; each grant vests 25 % at the first anniversary and then monthly. No shares were bought or sold—this is a baseline disclosure required under Section 16(a). The document contains no operating, financial, or strategic updates and is unlikely to affect the investment thesis for SRPT.
Insights
TL;DR: Routine Form 3 discloses CFO’s 17.7k shares and 31k options; informational only, negligible market impact.
The filing establishes Ryan Wong’s insider ownership after assuming the CFO role. The direct stake and sizeable option package align his incentives with shareholders but do not constitute new purchases or sales. Because Form 3s provide historical grant information rather than current transactions, they rarely move the stock. Strike prices largely exceed today’s trading range, so options are currently out-of-the-money, reinforcing a long-term performance focus. Overall impact is neutral.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to buy) | -- | -- | -- |
| holding | Stock Option (Right to buy) | -- | -- | -- |
| holding | Stock Option (Right to buy) | -- | -- | -- |
| holding | Stock Option (Right to buy) | -- | -- | -- |
| holding | Stock Option (Right to buy) | -- | -- | -- |
| holding | Stock Option (Right to buy) | -- | -- | -- |
| holding | Stock Option (Right to buy) | -- | -- | -- |
| holding | Stock Option (Right to buy) | -- | -- | -- |
| holding | Stock Option (Right to buy) | -- | -- | -- |
| holding | Stock Option (Right to buy) | -- | -- | -- |
| holding | Stock Option (Right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. Represents the date upon which the first twenty-five percent of the option granted vests. 1/48th of the total granted option vests and becomes exercisable on each monthly anniversary thereafter.
AI-generated analysis. How Rhea-AI works. Not financial advice.
